Saab: I Was Wrong, But The Selloff Creates Value

Saab is rated a buy with a $64.74 price target, implying 15% upside based on 2027 earnings expectations. Backlog visibility is strong, with 84% of 2026 revenue and over 70% of 2027 revenue already booked, supporting the outlook. Q1 sales rose 21.4% and EBIT increased 32%, though free cash flow is under pressure from elevated capex and ramp-up investments.

Analysis

Saab’s setup is less about near-term growth and more about the monetization of a multi-year capacity cycle. The market is likely underappreciating how short-cycle backlog converts visibility into pricing power: when a large share of out-year revenue is already booked, execution risk shifts from demand to industrial throughput, which supports multiple expansion if management keeps delivery slippage contained. The key second-order winner is the domestic and regional defense supply chain—electronics, sensors, machining, and specialty materials vendors should see sustained order flow as Saab ramps capacity, even if margins at the prime are temporarily diluted by investment spending.

The main tension is that FCF pressure is not just a timing issue; it can become a narrative problem if capex remains elevated while the stock is already discounting 2027 earnings. If working capital also expands alongside the ramp, the market may start to question the quality of earnings versus booked revenue, especially if European defense budgets move from headline support to contract conversion slower than expected. A secondary loser could be smaller competitors lacking the balance-sheet flexibility to pre-invest in capacity, because Saab can use backlog certainty to lock up suppliers and delivery slots before peers can respond.

The contrarian view is that consensus may be too focused on backlog visibility and too dismissive of execution bottlenecks. In defense ramp phases, the first derivative often looks great for several quarters, but the trade tends to break if investors realize that incremental revenue is not translating into proportional cash generation. That sets up a two-stage catalyst path: positive re-rating over the next 3-9 months if deliveries keep accelerating, followed by potential multiple compression over 12-18 months if capex intensity fails to normalize.

Net: this is attractive as a quality-growth defense compounder, but the cleaner risk/reward is to own it on pullbacks or via defined-risk structures rather than chase after a strong backlog print.

Key Decisions for Investors

• Long Saab on any 5-8% post-rally pullback; target a 12-18 month hold into 2027 earnings visibility, with the thesis dependent on capex intensity peaking within 2-3 quarters.
• Buy a call spread if listed options are liquid: 6-12 month upside participation while capping premium burn, appropriate because the near-term risk is multiple consolidation from free-cash-flow optics.
• Pair trade: long Saab / short a slower-growing industrial or defense prime with weaker backlog visibility, to isolate the backlog-to-revenue conversion premium over the next 2-4 quarters.
• If you already own the name, hedge with a trailing stop or overwrite strategy into strength; the main downside trigger is any evidence that ramp investments are not converting to operating leverage by the next two reporting cycles.
• Watch European defense-supplier names for confirmation; if subcontractor pricing tightens or delivery lead times lengthen, that is a sign the capacity cycle is still improving and Saab’s backlog may be more durable than the market assumes.